期刊文献+

糖尿病肾病患者血清Cys C、Hcy和尿mindin、NAG含量检测及对疾病早期诊断的价值 被引量:35

Detection of serum Cys C and Hcy as well as urine mindin and NAG contents in patients with diabetic nephropathy and value for early diagnosis of disease
下载PDF
导出
摘要 目的:研究糖尿病肾病患者的血清胱抑素C(Cys C)、同型半胱氨酸(Hcy)和尿mindin、N-乙酰-β-D氨基葡萄糖苷酶(NAG)含量及对疾病早期诊断的价值。方法:选择糖尿病肾病患者和单纯糖尿病患者进行研究,采集血清并测定Cys C、Hcy、PGF-2α、丙二醛(MDA)、晚期蛋白氧化产物(AOPP)、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)、VitE的含量,采集尿液并测定mindin、NAG、MST1、JNK、Foxos、Caspase-3、Caspase-12的含量。结果:糖尿病肾病尿液中mindin、NAG、MST1、JNK、Foxos、Caspase-3、Caspase-12的含量以及血清中Cys C、Hcy、PGF-2α、MDA、AOPP的含量均显著高于单纯糖尿病患者(P<0.05),血清中SOD、GSH-Px、VitE的含量显著低于单纯糖尿病患者(P<0.05);CKD分期越高,尿液中mindin、NAG、MST1、JNK、Foxos、Caspase-3、Caspase-12的含量以及血清中Cys C、Hcy、PGF-2α、MDA、AOPP的含量越高,血清中SOD、GSH-Px、VitE的含量越低(P<0.05);尿液中mindin、NAG含量与MST1、JNK、Foxos、Caspase-3、Caspase-12含量呈正相关(P<0.05);血清中Cys C、Hcy含量与PGF-2α、MDA、AOPP的含量呈正相关(P<0.05),与SOD、GSHPx、VitE的含量呈负相关(P<0.05)。结论:糖尿病肾病患者血清Cys C、Hcy和尿mindin、NAG含量在CKD1期即开始升高,同时与细胞凋亡、氧化应激损伤密切相关,有助于疾病的早期诊断。 Objective:study the serum cystatin C(Cys C)and homocysteine(Hcy)as well as urine mindin and N-acetyl-β-D-glucosa minidase(NAG)contents in patients with diabetic nephropathy and the value for early diagnosis of disease.Methods:Patients with diabetic nephropathy and patients with diabetes alone were selected for study,serum was collected to detect Cys C,Hcy,PGF-2α,malondialdehyde(MDA),advanced oxidation protein products(AOPP),superoxide dismutase(SOD),glutathione peroxidase(GSH-Px)and VitE contents,and urine was collected to detect mindin,NAG,MST1,JNK,Foxos,Caspase-3and Caspase-12 contents.Results:mindin,NAG,MST1,JNK,Foxos,Caspase-3and Caspase-12 contents in urine as well as Cys C,Hcy,PGF-2α,MDA and AOPP contents in serum of patients with diabetic nephropathy were significantly higher than those of patients with diabetes alone(P〈0.05),and SOD,GSH-Px and VitE contents in serum were significantly lower than those of patients with diabetes alone(P〈0.05);the higher the CKD stage,the higher the mindin,NAG,MST1,JNK,Foxos,Caspase-3and Caspase-12 contents in urine as well as Cys C,Hcy,PGF-2α,MDA and AOPP contents in serum,and the lower the SOD,GSH-Px and VitE contents in serum(P〈0.05);mindin and NAG contents in urine were positively correlated with MST1,JNK,Foxos,Caspase-3and Caspase-12contents(P〈0.05);Cys C and Hcy contents in serum were positively correlated with PGF-2α,MDA and AOPP contents(P〈0.05),and negatively correlated with SOD,GSHPx and VitE contents(P〈0.05).Conclusion:Cys C and Hcy in serum as well as mindin and NAG in urine of patients with diabetic nephropathy begin to increase from CKD1 stage,are closely related to cell apoptosis and oxidative stress injury,and help early diagnosis of the disease.
作者 王强
出处 《海南医学院学报》 CAS 2016年第10期980-983,共4页 Journal of Hainan Medical University
基金 河北省卫生厅项目(20130431)~~
关键词 糖尿病肾病 胱抑素C(Cys C) 同型半胱氨酸(Hcy) mindin N-乙酰-β-D氨基葡萄糖苷酶(NAG) 凋亡 氧化应激 Diabetic nephropathy Cystatin C Homocysteine Mindin NAG Apoptosis Oxidative stress
  • 相关文献

参考文献18

  • 1Sauriasari R,Andrajati R,Azizahwati,et al.Marker of lipid peroxidation related to diabetic nephropathy in Indonesian typediabetes mellitus patients[J].Diabetes Res Clin Pract,2015,108(1):193-200.
  • 2Jheng HF,Tsai PJ,Chuang YL,et al.Albumin stimulates renal tubular inflammation through an HSP70-TLR4axis in mice with early diabetic nephropathy[J].Dis Model Mech,2015,8(10):1311-1321.
  • 3Elsherbiny NM,Al-Gayyar MM,Abd El Galil KH.Nephroprotective role of dipyridamole in diabetic nephropathy:Effect on inflammation and apoptosis[J].Life Sci,2015,15(143):8-17.
  • 4Bouvet BR,Paparella CV,Arriaga SM,et al.Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2diabetes mellitus[J].Arq Bras Endocrinol Metabol,2014,58(8):798-801.
  • 5Ouchi M,Oba K,Motoyama M,et al.Postprandial glycemic control conditions in relation to urinary N-acetyl-β-D-glucosaminidase in patients with type 2diabetes mellitus without low glomerular filtration rate[J].Diabetes Technol Ther,2014,16(1):41-47.
  • 6Murakoshi M,Tanimoto M,Gohda T,et al.Mindin:a novel marker for podocyte injury in diabetic nephropathy[J].Nephrol Dial Transplant,2011,26(7):2153-2160.
  • 7Mao S,Xiang W,Huang S,et al.Association between homocysteine status and the risk of nephropathy in type 2diabetes mellitus[J].Clin Chim Acta,2014,20(431):206-210.
  • 8Wang H,Cui K,Xu K,et al.Association between plasma homocysteine and progression of early nephropathy in type 2diabetic patients[J].Int J Clin Exp Med,2015,8(7):11174-11180.
  • 9Asefy Z,Mirinejad M,Amirrasooli H,et al.Assessing validity of serum cystatin C for predicting metabolic syndrome[J].Pak J Biol Sci,2014,17(4):582-585.
  • 10傅美华,陈军,陈秋.胱抑素C与糖尿病肾病的相关研究进展[J].中国全科医学,2013,16(2):229-231. 被引量:64

二级参考文献41

  • 1黄晓华,卢丽珊.血清半胱氨酸蛋白酶抑制剂C在二型糖尿病肾病早期的应用价值[J].医学检验与临床,2008,20(5):42-43. 被引量:12
  • 2曹友德,李朝晖,李浩.糖尿病早期肾损伤患者尿视黄醇结合蛋白检测的临床意义[J].中国医学工程,2006,14(1):11-13. 被引量:10
  • 3孔岩,杨建梅,徐国宾,李淑葵,张春丽,郭晓蕙.对2型糖尿病患者肾小球滤过功能的评价[J].中华检验医学杂志,2007,30(11):1219-1222. 被引量:39
  • 4Yang W,Lu J,Weng J. Prevalence of diabetes among men and women in China[J].New England Journal of Medicine,2010,(12):1090-1101.
  • 5中国2型糖尿病防治指南制定委员会.中国2型糖尿病防治指南[M]北京:北京大学医学出版社,2010.
  • 6Macisaac RJ,Premaratne E,Jerums G. Estimating glomerular filtration rate in diabetes using serum cystatin C[J].Clinical Microbiology Reviews,2011,(02):61-67.
  • 7Yang YS,Peng CH,Lin CK. Use of serum cystatin C to detect early decline of glomerular filtration rate in type 2 diabetes[J].Internal Medicine,2007,(12):801-806.doi:10.2169/internalmedicine.46.6081.
  • 8Zhang PP,Zhan JF,Xie HL. Evaluation of glomerular filtration rate using cystatin C in diabetic patients analysed by multiple factors including tubular function[J].Journal of International Medical Research,2010,(02):473-483.
  • 9Grubb A,Bjrk J,Nyman U. Cystatin C,a marker for successful aging and glomerular filtration rate,is not influenced by inflammation[J].Scandinavian Journal of Clinical and Laboratory Investigation,2011,(02):145-149.
  • 10Jeon YK,Kim MR,Huh JE. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes[J].Journal of Korean Medical Science,2011,(02):258-263.

共引文献89

同被引文献331

引证文献35

二级引证文献284

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部